JPRN-jRCT1041210094招募中2 期
The Effectiveness of mirogabalin on oxaliplatin-induced peripheral neuropathy: A Multicenter phase 2 study
Watanabe Daichi0 个研究点目标入组 60 人开始时间: 2021年11月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who received oxaliplatin for the treatment of colorectal cancer, and tingling scores of 4 or more on the NRS scale in the hands or feet at the time of enrollment.
排除标准
- •Patients with peripheral neuropathy caused by other diseases at the time of registration, with concomitant diabetes mellitus for whom neuropathy is a concern at the time of enrollment, and patients who have started, discontinued, or had a dose change of 10% or more of duloxetine, acetaminophen, NSAIDs, high-dose aspirin, or opioids within 14 days of enrollment.
研究者
相似试验
招募中
2 期
Preventive effect of pregabalin on oxaliplatin-related neurotoxicity for patients with advanced/recurrent colorectal cancer: a prospective phase 2 studyColorectal CancerJPRN-UMIN000009464Toyama Prefectural Central Hospital40
已完成
不适用
Efficacy of goshajinkigan for oxaliplatin-induced peripheral neuropathy in colorectal cancer patientscolorectal cancerJPRN-UMIN000009956Chemotherapy unit, Kyoto Prefectural Univeersity of Medicine50
已完成
1 期
Phase I/II study of the combination of Oxaliplatin and S-1 in patients with advanced/recurrent colorectal cancerunresectable advanced/recurrent colorectal cancerJPRN-C000000443Outpatient Oncology Unit Kyoto University Hospital42
进行中（未招募）
不适用
Phase I/II study of oxaliplatin combined with melphalan in isolated hepatic perfusion for the treatment of liver metastases. - Oxaliplatin combined with melphalan in IHP.EUCTR2006-005088-25-NLeiden University Medical Center
尚未招募
不适用
Phase I/II study of oxaliplatin combined with melphalan in isolated hepatic perfusion for the treatment of liver metastases.liver metastasessecondary liver tumours10017991NL-OMON30309eids Universitair Medisch Centrum60